Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

143
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
143
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

336
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
336
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

181
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
181
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

244
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
244

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Post-release tuberculosis risk among formerly incarcerated populations in Lima Peru.

Nature communications·2026
Same author

Patient-Proposed Solutions to Financial Toxicity After Surgery: A Longitudinal, Multicenter Qualitative Study.

World journal of surgery·2026
Same author

Quantifying within-household tuberculosis transmission: a systematic review and prospective cohort study.

International journal of epidemiology·2026
Same author

Transmissibility and Disease Progression of Asymptomatic Mycobacterium tuberculosis Infection, Lima, Peru.

Emerging infectious diseases·2026
Same author

Pharmacokinetic and pharmacogenomic predictors of hepatotoxicity in the HIRIF trial for drug-susceptible tuberculosis.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

Depressive symptoms, violence, and discrimination among transgender women during the COVID-19 pandemic: a cross-sectional study.

Revista peruana de medicina experimental y salud publica·2026

Related Experiment Video

Updated: Jul 9, 2025

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
06:26

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Published on: July 28, 2023

2.3K

A costing framework to compare tuberculosis infection tests.

Amanda Brumwell1,2, Jade Tso3,4, Viswanath Pingali5

  • 1Advance Access & Delivery, Inc, Durham, North Carolina, USA brumwell@uw.edu.

BMJ Global Health
|November 30, 2023
PubMed
Summary
This summary is machine-generated.

Developing a framework for tuberculosis infection testing, this study found interferon gamma release assay (IGRA) offers greater accuracy and cost-effectiveness than tuberculin skin tests (TST). IGRA

Keywords:
ELISAdiagnostics and toolshealth economicshealth policytuberculosis

More Related Videos

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test
08:10

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test

Published on: April 9, 2012

80.8K
A Tuberculosis Molecular Bacterial Load Assay TB-MBLA
10:41

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA

Published on: April 30, 2020

14.0K

Related Experiment Videos

Last Updated: Jul 9, 2025

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
06:26

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Published on: July 28, 2023

2.3K
Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test
08:10

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test

Published on: April 9, 2012

80.8K
A Tuberculosis Molecular Bacterial Load Assay TB-MBLA
10:41

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA

Published on: April 30, 2020

14.0K

Area of Science:

  • Public Health
  • Infectious Disease Diagnostics
  • Health Economics

Background:

  • Tuberculosis (TB) infection testing relies on tuberculin skin tests (TST) and interferon gamma release assays (IGRA).
  • Accurate and cost-effective TB diagnostics are crucial in high-burden settings.
  • Comparing the practical costs and programmatic impact of TST versus IGRA is essential for optimizing TB control.

Purpose of the Study:

  • To develop and apply a framework for estimating the costs and programmatic impact of TB infection diagnostics.
  • To compare the cost-effectiveness of TST and IGRA in a high-burden TB area.
  • To inform decision-making for TB programs regarding diagnostic test selection.

Main Methods:

  • A seven-step framework was developed to estimate TBI prevalence, test accuracy, and associated costs.
  • Methodology included calculating costs of test administration, false negatives, and treatment.
  • The framework was applied in a peri-urban district of Lima, Peru.

Main Results:

  • Interferon gamma release assay (IGRA) demonstrated higher sensitivity than TST, reducing misdiagnosis costs.
  • TST incurred greater patient and staff productivity costs due to requiring two visits.
  • In Lima, IGRA benefits were estimated to outweigh infrastructural costs after 672 tests.

Conclusions:

  • The developed framework provides guidance for TB programs on selecting cost-effective TBI diagnostics.
  • IGRA offers a more accurate and potentially cost-saving alternative to TST, despite initial infrastructure concerns.
  • Accurate diagnostics should be viewed as investments that improve treatment outcomes and mitigate health system costs.